KM plot analysis for miR-130b using the TCGA and METABRIC breast cancer datasets revealed that the overall survival rate for patients with high-level miR-130b-3p expression was lower than that for those with low miR-130b among the ER-positive patients in all datasets (Fig. 6B). This evidence concerns the gene ESR1 and breast cancer.